Merck Valuation
| 6MK Stock | EUR 104.20 3.00 2.96% |
At this time, the firm appears to be overvalued. Merck secures a last-minute Real Value of €88.14 per share. The latest price of the firm is €104.2. Our model forecasts the value of Merck from analyzing the firm fundamentals such as Current Valuation of 288.86 B, price to sales of 4.74 X, and EBITDA of 17.9 B as well as examining its technical indicators and probability of bankruptcy.
Price Book 5.7796 | Enterprise Value 288.9 B | Enterprise Value Ebitda 12.0623 | Price Sales 4.7422 | Forward PE 23.9234 |
Overvalued
Today
Please note that Merck's price fluctuation is very steady at this time. Calculation of the real value of Merck is based on 3 months time horizon. Increasing Merck's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Merck stock is determined by what a typical buyer is willing to pay for full or partial control of Merck Co. Since Merck is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Merck Stock. However, Merck's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 104.2 | Real 88.14 | Hype 104.23 | Naive 99.48 |
The intrinsic value of Merck's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Merck's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Merck Co helps investors to forecast how Merck stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Merck more accurately as focusing exclusively on Merck's fundamentals will not take into account other important factors: Merck Cash |
|
About Merck Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Merck Co. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Merck based exclusively on its fundamental and basic technical indicators. By analyzing Merck's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Merck's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Merck. We calculate exposure to Merck's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Merck's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 48.6 B | 39.7 B |
Merck Quarterly Retained Earnings |
|
Other Information on Investing in Merck Stock
Merck financial ratios help investors to determine whether Merck Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Merck with respect to the benefits of owning Merck security.